DHR (Danaher Corporation) Company Assets

Official company branding of Danaher Corporation (DHR)

This daily price chart for Danaher Corp. (DHR) assets, valued at 87494.95, demonstrates the strength of the medtech giant. A global network of local plants ensures business stability. Monetization is driven by the sale of high-cost equipment followed by long-term pricing power over consumables. Meanwhile, autonomous procurement management within subsidiaries minimizes supplier dependency risks, maintaining high profitability.

DHR - Danaher Company Total Assets over the range 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Danaher Corp (DHR)

- price and consensus price forecast:
Stock Quotes danaher.com|DHR - Analyst Consensus Forecast
- business market valuation indicators:
Market Value Danaher Corporation Inc.|DHR - Enterprise Value
- balance sheet equity data:
Equity per Share Danaher|DHR - Book Capitalization|Market Capitalization to Book Value danaher.com|DHR - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Danaher Corp.|DHR - Long-Term Debt to Capital|Short-Term Debt to Capital Danaher Corporation Inc.|DHR - Company Debts|Debt to Book Capitalization Ratio Danaher Corporation Inc.|DHR - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Danaher|Interim Coverage Ratio danaher.com
- earnings and market ratios statistics:
DHR - Company Net Income
Basic company analysis:danaher.com, DHR
Core merchandise of Danaher Corp

Investors utilize this indicator as a gauge of fundamental stability and the business's resource potential. The metric is calculated inversely via daily ROA, combining equity and liabilities to assess total assets. The trend in total assets reflects the efficiency of capital management. For Danaher Corp. (DHR), this reflects the scale of investments in R&D and the development of high-tech biopharmaceutical equipment.

Key competitors

Cumulative Company Assets intuitive.com|BDX (Becton Dickinson) - Company Total Assets|Company Assets STERIS PLC STE|Company Total Assets WST|Baxter Healthcare - Total Business Assets|Company Total Assets MASI (Masimo Corporation)|Company Total Asset Base stevanatogroup.com (STVN)|Teleflex - Company Total Assets|Merit Medical Systems, Inc. (MMSI) - Cumulative Company Assets|NVST: Company Total Assets|ICU Medical Inc. (ICUI) - Company Total Assets|Aggregate Company Assets DENTSPLY SIRONA Inc.|Aggregate Company Assets LMAT|Cumulative Company Assets ATRC (AtriCure)|STAA (STAAR Surgical Co.) - Aggregate Asset Value|Company Total Assets NAGE (niagenbioscience.com)|Company Total Asset Base ZimVie Corp (ZIMV)|ANGO - Aggregate Company Assets|CERS (cerus.com) - Total Business Assets|Teknova (TKNO) - Aggregate Company Assets|MGRM - Company Total Asset Base|Cumulative Company Assets STSS|INFU (InfuSystem Inc) - Aggregate Business Assets|Aggregate Company Assets Utah Medical Products (UTMD)|KRMD (korumedical.com) - Aggregate Asset Value|Nyxoah - Cumulative Company Assets|Company Total Assets Microbot Medical, Inc. MBOT|PDEX - Aggregate Company Assets|Zentek Corp (ZTEK) - Cumulative Company Assets|ELUT: Company Total Assets|Company Assets milestonescientific.com (MLSS)|Aggregate Company Assets NEXGEL|Total Business Assets RVP (Retractable Tech)|Cumulative Company Assets HBIO (Harvard Bioscience)|Aggregate Business Assets FEMY|Aggregate Company Assets Meihua Medical Technologies Co., Ltd. MHUA|Company Total Asset Base Predictive Oncology Inc (POAI)|Callan JMB Corp - Company Total Assets|ATRI (Atrion Corp.) - Total Business Assets|NURO: Company Total Assets